Product Images Ganciclovir
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Ganciclovir NDC 14335-030 by Hainan Poly Pharm. Co., Ltd., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structures - image 01
Figure 1 - image 02
Figure 2 - image 03
ICM 1774 is a study or research related to CMV Retinitis. The available text data seems to show a chart or graph that displays the time to progression of CMV Retinitis in days (20, 60, 90, 120) from the start of maintenance therapy.*
Figure 3 - image 04
This is a graph showing the time to progression of Cytomegalovirus (CMV) retinitis. The x-axis represents the time from the start of maintenance therapy in days, with tick marks at 30, 60, and 120 days. The y-axis represents the percentage of patients who had experienced progression of CMV retinitis at the given time point, with a tick mark at 150%.*
Principal Display Panel - Vial Label - image 05
Ganciclovir for injection, USP is a cytotoxic and carcinogenic agent available in a 500mg/vial preparation for intravenous infusion. It must be handled with great care. Each vial contains ganciclovir sodium equal to 500mg of Ganciclovir. The solution may be diluted to a concentration of 10ml or less prior to use, with sterile water or USP injection. The solution should be shaken well before use and used within 12 hours. The package insert should be consulted for the appropriate dosage. It should be stored at 25°C with excursions permitted 0-13° or 30°C. Lot information is also given in the text.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.